Recognizing and Monitoring Symptoms of Abetalipoproteinemia (ABL)
At a Glance
Abetalipoproteinemia can cause oily stools, vomiting, diarrhea, and poor growth in infancy, then balance and vision problems from low fat-soluble vitamins. Vitamin tests and specialist exams can detect complications early; bleeding, vision loss, weakness, or inability to walk require urgent care.
Living with abetalipoproteinemia (ABL) involves monitoring a range of symptoms that change over time. Because the condition prevents your body from efficiently absorbing fat-soluble vitamins (A, D, E, and K), the “warning signs” you experience warrant clinical review of your laboratory levels and complications, not self-dosing [1][2]. Recognizing these signs early allows you and your care team to adjust your treatment plan before long-term damage occurs.
Key Safety Point: Never self-adjust your vitamin doses in response to new symptoms, as these treatments can be toxic if mismanaged. Any new ataxia, vision change, or persistent gastrointestinal distress requires a clinical evaluation by your specialist.
Early Signs in Infancy
For most, the first signs of ABL appear in the first few months of life. Because an infant’s body cannot package and transport dietary fats, the fat essentially “sits” in the digestive tract, causing immediate distress [3][4].
- Steatorrhea: This is the most common early sign. It refers to stools that are unusually pale, oily, and foul-smelling because they contain unabsorbed fat [1][3].
- Vomiting and Diarrhea: These symptoms often follow feedings and can lead to dehydration if not managed [1].
- Failure to Thrive: Because the infant is not absorbing calories from fat, they may not gain weight or grow at the expected rate [3][5].
Progression in Childhood and Adulthood
As a person with ABL grows, the symptoms shift from digestive issues to neurological and visual ones. This happens because vitamins E and A are critical for maintaining the health of your nerves and eyes [1][2].
- Neurological Changes: You may notice ataxia (a loss of coordination or balance), tremors, or muscle weakness [6][7]. This often starts with difficulty walking or a “clumsy” feeling in the hands and feet [1].
- Vision Loss: Chronic vitamin E and A deficiency can lead to retinitis pigmentosa-like retinal degeneration, where the back of the eye begins to break down [8]. Early signs include difficulty seeing at night or a gradual narrowing of your field of vision [2][9].
- Blood and Bone Health: Acanthocytosis—a condition where red blood cells become spiky and misshapen—is associated with ABL and can sometimes co-occur with anemia and fatigue, though it does not inevitably cause them [3][10]. Low vitamin D may lead to osteopenia, or weakened bones [11].
Managing Stable Symptoms
It is important to distinguish between “stable” symptoms and emergencies. If you are following a low-fat diet, you may still occasionally experience mild steatorrhea or oily stools after a meal that was slightly higher in fat than usual. While uncomfortable, this is a known part of living with ABL [10][12]. However, persistent steatorrhea, poor growth, vomiting, or diarrhea warrant a clinical review from your metabolic dietitian, rather than just restricting your calories further.
When to Seek Urgent Care
While most ABL symptoms develop slowly, certain situations require immediate medical attention to prevent permanent disability or life-threatening complications.
Emergency Red Flags
Seek medical care immediately if you or your child experience:
- Severe or Unexplained Bleeding: This includes heavy nosebleeds, easy bruising, or blood in the stool. It may signal a dangerous drop in vitamin K, which your body needs for blood clotting [10][1].
- Rapid Vision Changes: If you notice a sudden drop in vision or new “blank spots” in your sight, obtain urgent ophthalmologic assessment. This could reflect retinal detachment, hemorrhage, or choroidal neovascularization (abnormal blood vessel growth in the eye), which is an emergency but is often treatable if caught quickly [9].
- Severe Weakness or Breathing Difficulty: Difficulty breathing or swallowing requires immediate assessment, as it could be a sign of advanced neuromuscular complications or other causes [1][7].
- Sudden Inability to Walk: A rapid worsening of balance (ataxia) or a sudden loss of deep tendon reflexes (like the “knee-jerk” reaction) requires an urgent neurological evaluation [1][13].
Regular monitoring of vitamin levels and frequent check-ups with specialists can help you stay ahead of these symptoms and live a full, active life [5][13].
Common questions in this guide
What are the first signs of abetalipoproteinemia in a baby?
What symptoms can abetalipoproteinemia cause later in life?
When should someone with ABL seek emergency care?
Should I change my vitamin doses when symptoms appear?
How is abetalipoproteinemia monitored?
Get notified when new evidence is published on Abetalipoproteinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, et al.
Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.
PMID: 33994405 - 2
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.
Le R, Zhao L, Hegele RA
Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.
PMID: 35221233 - 3
A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.
Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.
Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.
PMID: 33258201 - 4
A Male Infant with Abetalipoproteinemia: A Case Report from Iran.
Rashtian P, Najafi Sani M, Jalilian R
Middle East journal of digestive diseases 2015; (7()):181-4.
PMID: 26396722 - 5
Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?
Sissaoui S, Cochet M, Poinsot P, et al.
Journal of pediatric gastroenterology and nutrition 2021; (73(1)):4-8 doi:10.1097/MPG.0000000000003145.
PMID: 33853111 - 6
Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years.
Cortier J, Vandamme S, Vanhauwaert D, et al.
Brain & spine 2023; (3()):101762 doi:10.1016/j.bas.2023.101762.
PMID: 38021030 - 7
Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
Triantafillidis JK, Manioti A, Pittaras T, et al.
Journal of personalized medicine 2025; (15(8)) doi:10.3390/jpm15080354.
PMID: 40863416 - 8
Ophthalmic diagnosis and optical coherence tomography of abetalipoproteinemia, a treatable form of pediatric retinal dystrophy.
Khan AO, Basamh O, Alkatan HM
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2019; (23(3)):176-177 doi:10.1016/j.jaapos.2019.01.005.
PMID: 30731125 - 9
Abetalipoproteinemia with angioid streaks, choroidal neovascularization, atrophy, and extracellular deposits revealed by multimodal retinal imaging.
Bijon J, Hussain MM, Bredefeld CL, et al.
Ophthalmic genetics 2024; (45(6)):583-590 doi:10.1080/13816810.2024.2411290.
PMID: 39373891 - 10
An Unusual Presentation of Hemorrhagic Disease in an Infant: A Probable Case of Abetalipoproteinemia.
Sivamurukan P, Boddu D, Pulimood A, Agarwal I
Journal of pediatric hematology/oncology 2021; (43(3)):e429-e430 doi:10.1097/MPH.0000000000001831.
PMID: 32433446 - 11
Low cholesterol states: clinical implications and management.
Gill PK, Hegele RA
Expert review of endocrinology & metabolism 2023; (18(3)):241-253 doi:10.1080/17446651.2023.2204932.
PMID: 37089071 - 12
Abetalipoproteinemia Due to a Novel Splicing Variant in MTTP in 3 Siblings.
Vlasschaert C, McIntyre AD, Thomson LA, et al.
Journal of investigative medicine high impact case reports 2021; (9()):23247096211022484 doi:10.1177/23247096211022484.
PMID: 34078172 - 13
A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.
Valmiki S, Bredefeld C, Hussain MM
Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.
PMID: 39672332
This page is for informational purposes only and does not constitute medical advice. It explains symptom monitoring in abetalipoproteinemia; do not change vitamin doses on your own, and contact your specialist about new or worsening symptoms.